Lucid Blue is a modern hybrid, though its exact origins and development history remain undocumented. While the strain is derived from Grateful Breath F2, the broader lineage and specific breeding objectives behind this cross have not been publicly confirmed by any source. Because of the scant historical documentation surrounding its emergence, the development timeline and original intent behind its selection remain largely a mystery, leaving its status as a cultivar defined by its performance rather than its pedigree.

The sensory profile of Lucid Blue is anchored by a complex terpene arrangement. Lab data confirms a dominance of limonene, followed by caryophyllene, linalool, myrcene, beta-pinene, humulene, pinene, bisabolol, and terpinolene. This specific blend of compounds suggests a diverse aromatic profile, though users should note that the cannabinoid content remains an estimated 19.7% THC, alongside negligible levels of CBD and an estimated 0.1% CBG. Its potential flavor and scent profile are heavily influenced by this primary limonene presence, which interacts with the subsequent caryophyllene and linalool to create its distinct chemical signature.

As a modern hybrid, Lucid Blue is well-suited for both indoor and outdoor cultivation, requiring a moderate level of grower expertise to reach its high-yield potential within a 53-day flowering window. Users consistently report effects that are relaxed, happy, and uplifted, making the strain a frequent choice for managing stress, pain, or sleep disturbances. Currently, there are no recorded notable offspring, and the strain continues to circulate as an independent representative of its limited genetic history.